2017
Hepatitis C virus treatment as prevention in an extended network of people who inject drugs in the USA: a modelling study
Zelenev A, Li J, Mazhnaya A, Basu S, Altice FL. Hepatitis C virus treatment as prevention in an extended network of people who inject drugs in the USA: a modelling study. The Lancet Infectious Diseases 2017, 18: 215-224. PMID: 29153265, PMCID: PMC5860640, DOI: 10.1016/s1473-3099(17)30676-x.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultAgedAged, 80 and overAntiviral AgentsChemopreventionCitiesComputer SimulationDisease Transmission, InfectiousFemaleHepatitis CHumansMaleMiddle AgedModels, StatisticalPrevalenceSubstance Abuse, IntravenousSurveys and QuestionnairesTime FactorsTreatment OutcomeUnited StatesYoung AdultConceptsBaseline HCV prevalenceHepatitis C virusHCV prevalenceInjection partnersPrevention strategiesTreatment coverageTransmission of HCVHepatitis C virus (HCV) treatmentHCV elimination strategySuccessful HCV treatmentC virus treatmentInjection drug usersHCV treatment coverageAdditional network memberHCV treatmentActing antiviralsC virusChronic infectionVirus treatmentDrug usersPrevalenceDrug abuseDrugsNational InstitutePrevention
1998
Prevalence and Incidence of Hepatitis C Virus Infection Among Young Adult Injection Drug Users
Garfein R, Doherty M, Monterroso E, Thomas D, Nelson K, Vlahov D. Prevalence and Incidence of Hepatitis C Virus Infection Among Young Adult Injection Drug Users. JAIDS Journal Of Acquired Immune Deficiency Syndromes 1998, 18: s11-s19. PMID: 9663618, DOI: 10.1097/00042560-199802001-00004.Peer-Reviewed Original ResearchConceptsYoung adult injection drug usersAdult injection drug usersInjection drug usersHepatitis C virus infectionC virus infectionHCV infectionVirus infectionDrug usersHCV-seronegative participantsTransmission of HCVCommunity-based outreachSecond-generation antibodiesHCV seroconversionHCV seroprevalenceCommunity outreach educationProspective studyRisk factorsSemiannual interviewsHigh riskInjecting practicesSterile syringesBivariate analysisLogistic regressionInfectionHCV
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply